Clinical indicators for common paediatric conditions: processes, provenance and products of the CareTrack Kids study by Wiles, L.K. et al.
RESEARCH ARTICLE
Clinical indicators for common paediatric
conditions: Processes, provenance and
products of the CareTrack Kids study
Louise K. WilesID
1,2,3, Tamara D. Hooper1,2,3, Peter D. Hibbert1,2,3,4,5,6, Charlotte Molloy1,2,
Les White2,7,8,9, Adam Jaffe7,10, Christopher T. Cowell11,12, Mark F. Harris13, William
B. Runciman1,2,3,4,5, Annette Schmiede14, Chris Dalton14, Andrew R. Hallahan15,
Sarah Dalton9,16, Helena Williams17,18,19,20,21,22, Gavin Wheaton23, Elisabeth Murphy9,
Jeffrey Braithwaite2*
1 Australian Centre for Precision Health, School of Health Sciences, Cancer Research Institute, University of
South Australia, Adelaide, South Australia, Australia, 2 Centre for Healthcare Resilience and Implementation
Science, Australian Institute of Health Innovation, Faculty of Medicine and Health Sciences, Macquarie
University, Sydney, New South Wales, Australia, 3 South Australian Health and Medical Research Institute
(SAHMRI), Adelaide, South Australia, Australia, 4 Centre for Health Systems and Safety Research, Australian
Institute of Health Innovation, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New
South Wales, Australia, 5 Australian Patient Safety Foundation, Adelaide, South Australia, Australia, 6 Centre
for Health Informatics, Australian Institute of Health Innovation, Faculty of Medicine and Health Sciences,
Macquarie University, Sydney, New South Wales, Australia, 7 Discipline of Paediatrics, School of Women’s
and Children’s Health, University of New South Wales, Sydney, New South Wales, Australia, 8 Sydney
Children’s Hospital, Sydney Children’s Hospitals Network, Randwick, Sydney, New South Wales, Australia,
9 New South Wales Ministry of Health, North Sydney, Sydney, New South Wales, Australia, 10 Department of
Respiratory Medicine, Sydney Children’s Hospital, Sydney Children’s Hospitals Network, Randwick, Sydney,
New South Wales, Australia, 11 Sydney Medical School, University of Sydney, Sydney, New South Wales,
Australia, 12 Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, Sydney Children’s
Hospitals Network, Westmead, Sydney, New South Wales, Australia, 13 Centre for Primary Health Care and
Equity, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia, 14 BUPA
Health Foundation Australia, Sydney, New South Wales, Australia, 15 Children’s Health Queensland Hospital
and Health Service, South Brisbane, Brisbane, Queensland, Australia, 16 New South Wales (NSW) Agency
for Clinical Innovation (ACI), Chatswood, Sydney, New South Wales, Australia, 17 Russell Clinic, Blackwood,
Adelaide, South Australia, Australia, 18 Australian Commission on Safety and Quality in Health Care, Sydney,
New South Wales, Australia, 19 Southern Adelaide Local Health Network, Bedford Park, Adelaide, South
Australia, Australia, 20 Cancer Australia, Surry Hills, Sydney, New South Wales, Australia, 21 Adelaide
Primary Health Network, Mile End, Adelaide, South Australia, Australia, 22 Country SA Primary Health
Network, Nuriootpa, Adelaide, South Australia, Australia, 23 Division of Paediatric Medicine, Women’s and




In order to determine the extent to which care delivered to children is appropriate (in line
with evidence-based care and/or clinical practice guidelines (CPGs)) in Australia, we devel-
oped a set of clinical indicators for 21 common paediatric medical conditions for use across
a range of primary, secondary and tertiary healthcare practice facilities.
Methods
Clinical indicators were extracted from recommendations found through systematic
searches of national and international guidelines, and formatted with explicit criteria for
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inclusion, exclusion, time frame and setting. Experts reviewed the indicators using a multi-
round modified Delphi process and collaborative online wiki to develop consensus on what
constituted appropriate care.
Results
From 121 clinical practice guidelines, 1098 recommendations were used to draft 451 pro-
posed appropriateness indicators. In total, 61 experts (n = 24 internal reviewers, n = 37
external reviewers) reviewed these indicators over 40 weeks. A final set of 234 indicators
resulted, from which 597 indicator items were derived suitable for medical record audit.
Most indicator items were geared towards capturing information about under-use in health-
care (n = 551, 92%) across emergency department (n = 457, 77%), hospital (n = 450, 75%)
and general practice (n = 434, 73%) healthcare facilities, and based on consensus level rec-
ommendations (n = 451, 76%). The main reason for rejecting indicators was ‘feasibility’
(likely to be able to be used for determining compliance with ‘appropriate care’ from medical
record audit).
Conclusion
A set of indicators was developed for the appropriateness of care for 21 paediatric condi-
tions. We describe the processes (methods), provenance (origins and evolution of indica-
tors) and products (indicator characteristics) of creating clinical indicators within the context
of Australian healthcare settings. Developing consensus on clinical appropriateness indica-
tors using a Delphi approach and collaborative online wiki has methodological utility. The
final indicator set can be used by clinicians and organisations to measure and reflect on
their own practice.
Introduction
Despite efforts aimed at achieving quality, equity, and sustainability of healthcare systems[1–
5], gaps remain between the care that is recommended (appropriate care, in line with evidence
and/or clinical practice guidelines (CPGs)) and that which is delivered[6, 7]. To prioritise
resources and develop strategies to address the inappropriateness of and variations in care[8],
national measurement and monitoring activities are needed to capture what population-level
care is given, and by whom[9–12]. Internationally, clinical standards and indicators are
increasingly being used to identify gaps and areas for improvement, and understand and mea-
sure the quality of healthcare provided[13–22]. Data evaluating appropriateness of healthcare
for children is limited, especially at population level[23, 24].
Interventions aimed at delivering care in line with CPGs mostly report limited or variable
success[25–31]. However, there is some evidence that both compliance with accepted care pro-
cesses and favourable clinical outcomes are possible[26, 27, 32–35], and may be facilitated by
multi-faceted nationally-based initiatives using clinical indicator-based adherence approaches
coupled with audit and feedback[36–41].
Clinical indicators can be developed using one of three main systematic approaches[42–
44]: evidence, such as using scientific data from clinical trials[45–47]; combining evidence
with consensus, such as a Delphi technique[17, 48] or RAND appropriateness method[23, 49,
50]; and CPG-driven derivation from recommendations in current CPGs[19, 51, 52]. While
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the merits and demerits of different clinical indicator development methods have been
explored[53–56], the trend for contemporary indicator development centres on employing
hybrid approaches[22, 57, 58].
As interpretation of performance measured by clinical indicators can have far-reaching
consequences (e.g. public reporting, pay-for-performance), it is important to ensure that they
are developed in a way that reflects what is reasonably expected of clinicians[57]. For example,
for the purposes of a medical record audit, this may be best achieved through combining con-
sensus-based (i.e. stakeholder perspectives / expert opinion) and CPG-driven (i.e. recommen-
dations to clinicians to guide care). The Delphi technique, a structured process comprised of
several rounds of review to gather stakeholder perspectives until consensus is reached[17], can
be used to vet recommendations derived from CPGs to develop healthcare quality indicators
[17]. While a number of studies have used combined methods to create clinical indicators, of
these most focus on a single condition[58, 59], clinical area or care process[60, 61] or health-
care setting[62, 63].
Built on the findings and experience of the CareTrack Australia study[11, 51], the objective
of the CareTrack Kids study was to determine the appropriateness of healthcare delivered to
children in Australia for common conditions[64]. This paper describes a core component of
the CareTrack Kids study; the development of a set of clinical appropriateness indicators for
common paediatric conditions for use across a range of healthcare practice facilities, including
primary care provided by general practitioners, secondary care provided by outpatient paedia-
tricians and tertiary care in hospitals[65]. Our method married recognised Delphi processes
[17] with a collaborative online wiki[66] to achieve consensus on what constitutes appropriate
care, using CPGs as a primary information source. We report on this indicator development;
detailing the processes (panel recruitment; methods of indicator development and criteria for
selection), provenance (origin and evolution of original recommendations and indicators
throughout the study including reasons for exclusion) and products (characteristics of the
final set of indicators including linking these to evidence levels and grades of
recommendations).
Methods
The three components of our indicator development work[65] were to (1) identify and select
common candidate paediatric conditions (presented in our study protocol[65]), (2) develop
clinical indicators representative of “appropriate care” for these conditions, and (3) refine
them for feasibility, applicability and utility. Our approach has been described in our study
protocol[65]. Terms used in CTK and their definitions are presented in Box 1. This study was
Box 1. Definitions of terms used in the CareTrack Kids study.
A clinical practice guideline (CPG):
“Statements that include recommendations intended to optimise patient care that are
informed by a systematic review of evidence and an assessment of the benefits and
harms of alternative care options.”[67, 68]
A clinical standard[11]:
• is an agreed process that should be undertaken or an outcome that should be achieved
for a particular circumstance, symptom, sign or diagnosis (or a defined combination
of these)
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approved by the Macquarie University Human Research Ethics Committee (protocol
5201401120).[65]
We initially identified 21 common paediatric conditions (Box 2). Clinical indicators repre-
sentative of their appropriate care were developed, using a four-stage process:
1. systematic search and source relevant CPGs;
2. select, draft and format proposed clinical indicators;
3. review indicators internally and externally (via a modified Delphi approach); and
4. refine and convert indicators to individual medical record audit indicator items suitable for
use in a wide range of circumstances[64].
• should be evidence-based, specific, feasible to apply, easy and unambiguous to mea-
sure, and produce a clinical benefit and/or improve the safety and/or quality of care, at
least at the population level.
If a standard cannot or should not be complied with, the reason/s should be briefly stated.
A clinical indicator[11]:
• describes a measurable component of the standard, with explicit criteria for inclusion,
exclusion, time frame and setting.
A clinical tool[11, 69–72]:
• should implicitly or explicitly incorporate a standard or a component of a standard
• should constitute a guide to care that facilitates compliance with the standard
• should be easy to audit, preferably electronically, to provide feedback
• should be able to be incorporated into workflows and medical records.
Appropriate care[11, 51, 73]:
• care in line with evidence-based or consensus-based guidelines
A wiki[66, 74, 75]
• is an interactive information management system which will allow users (e.g. health-
care professionals who register for, and login to the wiki) to collaborate directly in for-
mulating and refining indicators that are relevant to their clinical practice and lived
experience.
Underuse[76]
“Failure to deliver a service that is highly likely to improve the quality or quantity of life,
that represents good value for money, and that patients who were fully informed of its
potential benefits and harms would have wanted.”
Overuse[76]
“Provision of a service that is unlikely to increase the quality or quantity of life, that
poses more harm than benefit, or that patients who were fully informed of its potential
benefits and harms would not have wanted.”
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Stage 1 Search and source relevant CPGs
Clinical indicators were derived from published CPGs relevant for 2012 and 2013. A system-
atic search was undertaken, in order of priority, for national-level CPGs from Australia (e.g.
from the National Health and Medical Research Council (NHMRC))[77], and internationally
[78–80]. In the absence of Australian, national or international CPGs, those from relevant pro-
fessional medical colleges and associations were examined, as well as those from state jurisdic-
tional bodies or professional groups [81, 82]. Three Research Group members (LKM, TDH,
PDH) conducted the CPG searches and developed the initial set of clinical indicators. Full
details of the search strategy are provided in online S1 Table of our protocol paper[65].
Box 2. Paediatric conditions included in the indicator development
process in the CareTrack Kids study (n = 21)
Acronym Condition
ABDO Acute abdominal pain











GORD Gastro–Oesophageal Reflux Disease
+ HEAD Head injury
+ OBES Obesity
OTIT Otitis media
+ PREV Preventive care
SEIZ Seizures
TONS Tonsillitis
URTI Upper Respiratory Tract Infection
URIN Urinary Tract Infection
+ NHPA National Health Priority Area
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Stage 2 Select, draft and format the proposed indicators
Recommendations from each CPG were extracted verbatim, along with their documented
grade or level of evidence, and compiled in a Microsoft Excel spreadsheet. In instances where
there was more than one guideline for a recommendation, we recorded all grades and levels of
evidence. Similar recommendations across CPGs were grouped together to minimise duplica-
tion. Not all published recommendations became indicators; using our experience of develop-
ing and ‘field-testing’ 522 indicators in the CareTrack Australia (adult) study[51], we applied a
set of exclusion criteria (Table 1) based on:
• Strength/certainty of the wording of the recommendation (i.e. “may”, “could” and “con-
sider” statements were excluded)
• Low likelihood of information being documented in the medical record
• Guiding statements without recommended actions
• Out of scope of the CTK study (i.e. “structure-level” recommendations aimed at attributes of
the settings in which care is delivered[12, 43]).
All clinical indicators were written in a structured and standardised format, commencing with
the inclusion criteria followed by the compliance action[51]. For example, the inclusion criteria
defined the age (infant, child, adolescent), condition, and the phase of care (at diagnosis/presentation
or “with”, indicating the diagnosis is existing). The compliance action defined the recommended
appropriate care. Indicators were arranged chronologically according to phases of care (Table 2).
Stage 3 Subject the indicators to several rounds of internal and external review
There were two stages involved in the indicator review (Fig 1). The proposed clinical indicators
were subjected to an internal review (Stage 3a), followed by an external wiki style review (Stage
3b) using a modified Delphi process[87]. This multi-round, multi-modality approach aimed to
enhance methodological rigor and optimise consensus with respect to the content and face
validity of the final set of clinical indicators [17]. We conducted three rounds for the internal
review (Stage 3a), and two rounds in the external review (Stage 3b).
Stage 3a Internal review processes
In accordance with selection strategies employed within the Delphi process literature[17, 88],
internal reviews were conducted by paediatricians and general practitioners who were
Table 1. Examples of current recommendations which would meet exclusion criteria.
Indicator eligibility
criteria
Example exclusions Rationale for exclusion
Strength/certainty of
wording
Healthcare professionals who routinely use disposable chemical dot
thermometers should consider using an alternative type of thermometer
when multiple temperature measurements are required [83].
Use of term “consider” does not provide a certain or




People with autism are not prescribed medication to address the core
features of autism [84]
The rationale for prescribing medication in this context is
unlikely to be documented in a medical record
Guiding statement without
recommended action
Be aware that the aim of weight management programmes for children
and young people can vary. The focus may be on either weight
maintenance or weight loss, depending on the person’s age and stage of
growth [85].
Guiding statement with no specific actions able to be used to
determine compliance
Out of CTK scope Streamlined referral pathways should be developed for tests not available
or appropriate in primary care [86]
Structure-level recommendation for which data cannot be
obtained by way of a medical record audit
https://doi.org/10.1371/journal.pone.0209637.t001
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identified by the research team and their professional networks. Clinical Champions, who led
the internal review panel members, were employed as the head or director of a relevant paedi-
atric department in a large hospital, held at least an adjunct academic appointment or were
directly involved in clinical care. The clinical indicators for each condition were reviewed via
email by a panel of at least three reviewers. Reviewers completed their assignments indepen-
dently to minimise bias from “group-think”[89, 90].
The review criteria were based on methods developed in previous US and Australian stud-
ies[23, 49, 51]. Internal reviewers were asked to: score each indicator using one of three
responses (yes, no, not applicable to area of expertise or clinical setting) against three key crite-
ria; acceptability, feasibility and impact (Box 3)[65]; to recommend the indicators for inclusion
or exclusion; and provide any additional comments. Research Group members (LKW, TDH,
PDH) collated the feedback and revised the content, structure, and format of each indicator
between review rounds.
Stage 3b external wiki-based review
External reviews were conducted by invited paediatricians and general practitioners. Relevant
medical colleges, professional associations and networks were contacted, requesting assistance
with the recruitment of clinical experts to register as external reviewers. Invitations comprised
direct email requests to members, media releases and articles within newsletters. Clinical
experts self-nominated as reviewers for one or more of the CTK conditions based on their
interest, scope of practice and clinical experience[17, 88]. All reviewers were required to com-
plete a Conflict of Interest (COI) declaration[91–93]; COIs were recorded for each reviewer
and managed according to the NHMRC protocol[94].
Indicators for each condition (from round three of the internal review) were posted to an
online wiki site. The aim was for each condition to be independently reviewed by a minimum
of nine experts. In addition to the scoring criteria used in the internal review process, indica-
tors were scored on a nine-point Likert scale as representative of appropriate care delivered to
children during 2012 and 2013[23, 51, 95]. With the support of a Research Group member as a
wiki site Administrator, the Clinical Champion for each condition followed-up and managed
external reviewers’ responses, and made final recommendations regarding the inclusion, con-
tent, structure and format of indicators (Table 3). For most conditions, the Clinical Champi-
on’s role was undertaken by one of the Stage 3a internal reviewers. In the second wiki round,
experts had access to de-identified comments from the first round.
Table 2. Examples of clinical indicators from CareTrack Australia [51] that were written in a structured and stan-
dardised format.
Condition Phase of care Indicator (number)
Obesity Screening Patients who are being assessed for obesity should have their BMI and waist
circumference measured at least once in 2 years (469).
Depression Diagnosis Patients newly diagnosed with depression had their co-morbidities documented
(332).
Asthma Treatment Patients who presented to an emergency room or to their GP with an
exacerbation of asthma and a PEFR/peak flow or FEV1 less than 70% of baseline
were prescribed an inhaled corticosteroid (106).
Diabetes Ongoing
management
Patients with existing type 2 diabetes were referred to a dietician or provided with
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Fig 1. Overview of the internal and external indicator review process.
https://doi.org/10.1371/journal.pone.0209637.g001
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Consensus business rules. For the Stage 3 internal and external reviews, consensus was
defined as the majority agreeing to include or exclude; when a clear majority was not able to
be achieved we opted to retain the indicator and subject it to additional feedback over subse-
quent rounds of review. In order to facilitate consensus, the Research Group and wiki Admin-
istrator and Clinical Champion used comments fields to provide indicator reviewers with a
summary of the feedback obtained to date, where relevant
Box 3. Information for scoring criteria for clinical indicators[65]
Acceptability (A)
• Level of evidence or grade of recommendations. In some instances a level of evidence
or grade of recommendation may not have been provided. In these cases, absence of
evidence should not be the only grounds for exclusion of the indicator (i.e. expert con-
sensus may be acceptable).
• Non-Australian clinical guideline recommendations. There are some indicators where
the primary source is a non-Australian clinical guideline from a reputable organisation
(e.g. NICE). In the absence of Australian guidelines, it is important to consider
whether such a guideline reflects what is practical within the context of Australian
healthcare settings.
• Non-national Australian clinical guideline recommendations. In the absence of
nationally-based Australian AND international guidelines, some indicators have been
sourced using guidelines from one state or organisation e.g. NSW Health, or Royal
Children’s Hospital in Melbourne.
• Recommendation is made in more than one clinical guideline.
• Reflects “essential” (i.e. independent of resources) Australian clinical practice during
2012 and 2013.
Feasibility (F)
• Indicators with multiple eligibility criteria tend to have lower numbers of eligible
encounters.
• Compliance can be determined preferentially from one encounter with one healthcare
provider, or at least within a 1–2 year period (our sample will be the medical records
of healthcare encounters for children during the 2012–2013 period).
• Likely to be documented in the medical record, for example: indicators associated
with lifestyle or exercise advice are less likely to be documented.
Impact (I)
• “High impact” on the patient in terms of domains of quality i.e. safety, effectiveness,
patient experience, or access.
• “High impact” within Australian healthcare settings (e.g. what will be the frequency/
prevalence of presentation).
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Stage 4 Refine and convert indicators to individual medical record audit
indicator items
During the Stage 4 refinement process, we flagged indicators with an appropriateness score of
less than 7, or more than three inclusion criteria, as these are likely to have lower prevalence,
and sought the condition Clinical Champion’s approval for their exclusion. For all indicators
approved for inclusion, the Research Group converted each inclusion criterion and compli-
ance action into an individual medical record audit indicator item and formatted these such
that “not applicable” (i.e. medical record did not meet the indicator’s inclusion criteria) or
binary responses (yes/no) could be recorded (S1 Table). We also analysed the final set of indi-
cators to ensure all phases of care were covered, and that the relevant indicators were ‘feasible’
for the main medical record audit[64]. Each Clinical Champion checked the individual medi-
cal record audit indicator items for their nominated condition to ensure the ‘spirit’ of the origi-
nal recommendations and reviewers’ feedback from previous rounds had been accurately
captured.
Data analysis
Reviewers’ scores and comments from the internal (manually entered) and external (exported
from the wiki) reviews were entered into Microsoft Excel (2013) spreadsheets. Analysis and




A panel of 24 experts completed the internal review; each condition was allocated at least three
reviewers, and each reviewer undertook reviews for no more than three conditions. For the
external review, 79 participants registered and were approved for the wiki site; 37 (47%) under-
took the Round 1 review for their nominated condition(s), and 24 (30%) went on to complete
Round 2. The demographic characteristics of indicator reviewers are presented in Table 4. In
the external review, there was a mean of 5 (SD 2.7) reviewers per condition (range 1–14;
median 4) (S1 Table).
Provenance
We identified 113 relevant CPGs with supporting references, from which 1432 original recom-
mendations were extracted. Over one-fifth of extracted recommendations (n = 334, 23%) were
initially excluded by the Research Group (S2 Table). The information contained in some of
Table 3. Clinical champion management of external reviewers’ responses.
Options Reason Implication
Mark as final • High ‘appropriateness’ scores
• Good agreement among external
reviewers
External reviewers required to provide final approval
(yes/no) in Round 2
Mark updated • Consistent feedback from external
reviewers suggesting changes
• Evidence exists/provided to support
suggested changes
External reviewers required to rescore updated
indicator using original criteria (Box 3)
Reject (add
reason)
• Low ‘appropriateness’ scores
• Good agreement among external
reviewers to reject
External reviewers provided with the rationale for
rejecting indicators
https://doi.org/10.1371/journal.pone.0209637.t003
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these exclusions was covered in other recommendations which were included in our sample
(n = 86 of 334, 26% of guiding statements; and n = 3, 4% of those excluded due to strength/cer-
tainty of wording) (S2 Table). In addition, a small proportion of the excluded guiding state-
ments (n = 3, 1%) were incorporated into definitions which were to be provided to research
surveyors to assist them in completing the medical record audit.
The remaining original recommendations (n = 1098) were used to draft 451 proposed indi-
cators for circulation among the internal review panel members (Fig 2). Following three
rounds of internal review, almost half were rejected (n = 206, 46%) mainly due to concerns
around the feasibility of capturing indicator information by way of a medical record audit (e.g.
likelihood of the necessary documentation being present) (S3 Table). During the internal
review, 245 indicators were approved for posting to the wiki for the external review, together
with twenty-one ‘new’ indicators (S4 Table) developed by splitting existing indicators which
contained more than one eligibility criterion and/or compliance action. The external review
yielded 257 indicators (97%), with the main reasons for exclusion mirroring those from the
internal review (Fig 2). S5 Table and Fig 3 present, by condition, the evolution of numbers of
indicators over the development process, from original recommendations to the final indica-
tors and medical record audit indicator items.
Table 4. Characteristics of indicator reviewers.
Internal review N %
Profession
Paediatricians 15 63
General practitioners 7 29
Psychiatrists 2 8
Additional appointments
Formal university affiliation 9 38
Director Medical Unit / Hospital Service 5 21
Research network/institute membership 4 17
Government health department 2 8
External review N %
Profession#
Medically trained 35 83
Paediatricians 29 83�






Private practice 4 10
Health-related government department^ 3 7
Appointments#
Formal university affiliation 26 62
Research network/institute membership 2 7
Professional association role 2 7
National accreditation organisation 2 7
# presented as a percentage of reviewers who completed either Round 1 or Round 2 (n = 42)
� presented as a percentage of medically-trained professionals
^ n = 1 had a joint appointment across hospital and government settings
https://doi.org/10.1371/journal.pone.0209637.t004
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Fig 2. Provenance of CPGs, original recommendations, indicators and medical record audit indicator questions. � some indicators were rejected for
more than one reason ^ ‘appropriateness’ score less than seven out of nine.
https://doi.org/10.1371/journal.pone.0209637.g002
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Products: Indicators and medical record audit indicator items
The final 234 indicators were used to develop 597 individual medical record audit indicator
items for the medical audit review (Table 5, S1 Table). In terms of classification according to
phase of care, most medical record audit indicator items related to ‘treatment’ (n = 273, 46%)
(S6 Table). Most items were geared towards capturing information about under-use in health-
care (n = 551, 92%) across emergency department (n = 457, 77%), hospital (n = 450, 75%) and
general practice (n = 434, 73%) healthcare facilities, and were based on consensus level recom-
mendations (n = 451, 76%).
Discussion
To our knowledge, this is the first study to detail the processes, provenance and products of
developing clinical indicators of appropriate care for a range of common paediatric conditions
for use across Australian primary, secondary and tertiary healthcare practice facilities. Paediat-
ric indicator development studies over the last decade have focused on fewer paediatric condi-
tions[23, 96, 97] or specific types of illnesses and/or healthcare practice facilities[96–99]. Our
methodology was strengthened by employing a transparent, multi-stage and multi-modality
modified-Delphi process which aimed to contextualise the recommendations published in
CPGs (including scientific evidence) to the clinical setting (expert opinion). The Delphi proce-
dure was reported in accordance with current recommendations[17] (S7 Table). Using our
approach and definitions, we were able to achieve consensus on appropriate care for 21 paediat-
ric conditions (in Australia for the years 2012–2013), and embody these in clinical indicators.
Fig 3. Evolution of the total number of indicators over the development process, from original recommendations to the final medical record audit indicators and
indicator items.
https://doi.org/10.1371/journal.pone.0209637.g003
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The main reason for excluding indicators was feasibility which included multiple eligibility
criteria, compliance unlikely to be determined during a medical record audit, low likelihood of
information being documented (Box 3, Fig 2), and is supported by internationally-recognised
organisations[22] and literature[17]. A potential consequence of this is that using ‘feasibility’
as an eligibility criterion may serve to drag down the standard of measuring what is deemed
appropriate care towards the care we are expecting to be documented rather than that which
should be delivered. Recommendations were also excluded due to the strength/certainty of
their wording (e.g. “may”, “could”, “consider” statements), which means that our indicator set
did not cover aspects of care that may be influenced by situational factors and/or patient pref-
erences; this presents a gap in their clinical utility. A first step to capturing information about
these aspects of care is improving the detail and consistency of clinicians’ documentation (e.g.
consideration of differential diagnoses, decision making based on situational factors and/or
patient preferences). In the future, and as standardised electronic medical records become
more commonplace and sophisticated, this may be facilitated by structured and mandatory
fields of entry[11], as well as shared access and decision-making between patients and clini-
cians using integrated electronic apps and medical record software to inform, guide and record
care; and especially variations in care as a result of situational factors or preferences [100, 101].
Application of the CTK indicators for research purposes has been described in the main
results paper [102] and a condition-specific analysis for tonsillitis [103]. While originally
developed for use in a large-scale research medical record audit, the CTK indicator set can be
used by clinicians and organisations to measure and reflect on their own local practice
(Table 6). In this way, data can be aggregated by individuals or groups of practitioners, hospital
Table 5. Examples of indicators with multiple inclusion criteria and/or compliance actions being converted into individual medical record items.
Indicator Item no. Item Rationale
Children aged between 2–16 years are diagnosed as follows:
- overweight (if BMI for age and sex in 85th - 94th percentile) OR
- obese (if BMI for age and sex greater than 95th percentile).
OBES01 Children aged between 2–16 years with a BMI for age




OBES02 Children aged between 2–16 years with a BMI for age
and sex greater than 95th percentile were diagnosed as
obese.
Children and adolescents with depression are provided with:
- evidence-based management of depression (e.g. information
leaflets/booklets/reliable websites such as Beyond Blue, Black Dog
Institute) AND
- offered community supports (e.g. information about support
services, such as Lifeline phone number, Community mental health
team).
DEPR06 Children and adolescents with depression were provided









Table 6. Guidance on the clinical application of the CTK indicators in a medical record audit.
CTK indicator
feature
Clinical application in a medical record audit
HCP type Specifies the setting(s) for which each indicator is applicable
Inclusion criteria • Specifies the patients who are eligible to have their documented care assessed against the
indicator
• The number of patients within a sample who are eligible form the denominator in
calculations of percentage adherence
Compliance action • The number of patients within a sample whose care was adherent to the compliance action
form the numerator in calculations of percentage adherence
https://doi.org/10.1371/journal.pone.0209637.t006
Clinical indicators for paediatric conditions: Processes, provenance and products of the CareTrack Kids study
PLOS ONE | https://doi.org/10.1371/journal.pone.0209637 January 9, 2019 14 / 23
departments and local or jurisdictional health networks to determine baseline adherence with
recommended care [104–106], and identify and target practice gaps with professional develop-
ment and other quality improvement activities. For aspects of care that are not covered by the
current CTK indicator set, supplementary data collection methods such as case studies, patient
satisfaction surveys, narrative-text analyses of clinical notes, and clinician/patient interviews
may need to be considered[107].
There are several caveats to our findings. First, the final set of clinical indicator items was
based on recommendations in CPGs relevant for the years 2012–2013, with priority given to
those published in Australia. While this limits the applicability and generalisability of the indi-
cators beyond these contexts, they do provide a basis from which new indicators may be
derived and adapted to local settings. We did not critically appraise the quality of included
CPGs; for three conditions (i.e. acute abdominal pain, head injury, and preventive care) we
were unable to identify CPGs where “a systematic review of evidence and an assessment of the
benefits and harms of alternative care options” had been undertaken by the CPG developers to
inform the recommendations[67, 68]. As a result, we accepted CPGs and protocols for manag-
ing care produced at state, national or local hospital level which means that there was little
depth to the evidence base underpinning the indicator sets for these three conditions. Grades
of recommendation and levels of evidence were recorded verbatim from included CPGs.
CPGs did not consistently report sufficient information about the primary evidence or deci-
sion-making used to formulate recommendations to allow the author team to uniformly apply
an established evidence grading system to extracted recommendations, such as GRADE[108].
As a reflection of the CPGs from which they were born, the majority of medical record audit
indicator items were based on consensus-level recommendations and pertained to under-use
(S6 Table). However, in recent years there has been growing awareness of ‘overuse’ of health-
care resources(6, 9, 76, 104, 105) and to perceive this as a source of not only waste but of
healthcare related harm(11, 106). We found 45 (8%) of our indicator items sought to evaluate
some aspect of over-use. A range of national standards and accreditation processes (e.g.
Choosing Wisely(109)) are working to champion reduction of over-use and unwarranted
healthcare variation(3, 14) and low value care(9, 15).
Second, the indicators represent the opinions of individuals who chose to participate in this
study. Internal review panel members were non-randomly selected for invitation, and external
reviewers were targeted through relevant medical colleges, professional associations and net-
works which may have skewed our sample or amplified any effects of self-selection bias. We
met our goal of achieving at least nine external reviewers for only one (BRON) of the 21 condi-
tions (S1 Table); attracting a lower critical mass of experts than expected may limit the face
validity of our indicator sets when applied to the clinical setting (e.g. response bias, non-repre-
sentative process measures, reduced endorsement and uptake in the wider community)[109,
110].Tempering this, our internal review panel had extensive clinical and quality improvement
experience in paediatric care in Australia, and most external reviewers had university-based
affiliations in addition to their clinical roles which may have assisted to refine the indicators in
a manner underpinned by both scientific evidence and clinical experience. Importantly, paedi-
atricians working in hospital settings dominated our expert panels; their review of clinical
indicators geared towards capturing information about care provided in general practice may
have lacked relevance. Patient and public involvement in guideline development aims to
improve patient-centred health care provision, foster democratic healthcare policy-making,
and enhance the quality of healthcare and related policy[111]; CTK indicators were developed
without patient consultation, which is a limitation of our process.
Third, we did not formally evaluate the methodological rigor of our indicator development
process with a validated quality appraisal tool, such as AIRE (Appraisal of Indicators through
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Research and Evaluation). While this paper reports on aspects related to the first three AIRE
domains (Purpose, relevance and organizational context; Stakeholder involvement; Scientific
evidence)[112], further details about the fourth AIRE domain (Additional evidence, formula-
tion, usage) are available in the supplementary material of the results paper of the CareTrack
Kids multistage stratified sample medical record review. Our development process did not
involve reviewers meeting face to face. The use of online technologies was specifically chosen
to enhance transparency, accessibility and timeliness of the development process and minimise
“group-think”[69, 75]; however it could be argued that an opportunity for reviewers to meet
may have stimulated useful discussion on contentious issues[97, 113]. While we did encourage
experts to make comments (which were included in de-identified format with the next itera-
tions of indicators presented to reviewers in subsequent rounds) in both Stages 3a and 3b,
information from the internal review was not able to be conveyed to external reviews (due to
project and wiki system constraints).
Based on our experience, and emerging standards around new approaches for evidence
development[68], it is recommended that future clinical indicator developers look to further
harness available technology such as wikis to help facilitate the rate at which consensus can be
achieved, and to optimise its transparency (i.e. ability to capture discussion threads) and reach
[11], and include patients within review panels to ensure their perspectives as key stakeholders
are captured and considered[114, 115]. However, as an interim step and to address the issue of
feasibility of measurement and clinical utility of indicators), qualitative research seeking
insights from those who develop CPGs, indicators, and medical record software and tools[11,
69–71] as well as users (e.g. clinicians, healthcare organisations), could help to bridge the gaps
between what we consider to be appropriate care, how it may be relevantly documented, and
used to evaluate the quality of clinical practice.
Conclusion
Findings from the modified Delphi approach presented in this study address recommendations
for methodological rigor and transparency of reporting[17], and provide an inventory of our
experiences and learnings from developing clinical indicators of appropriate care for common
paediatric medical conditions. In a critical next step, these clinical indicators will form the criteria
against which the CTK study can, for the first time in Australia, measure appropriateness of paedi-
atric care in 2012 and 2013[64]. Our Delphi approach could be used by others to refine this suite
of clinical indicators to local contexts to assist point-of-care decision-making, or providing a start-
ing point for undertaking similar analyses of healthcare practices for benchmarking purposes.
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